secwatch.observer — SEC 8-K summary
======================================

Issuer:     RHYTHM PHARMACEUTICALS, INC. (RYTM)
CIK:        0001649904
Form:       8-K
Filed at:   2024-07-10T23:59:59+00:00
Accession:  0001104659-24-078941
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Rhythm Pharmaceuticals files prospectus for resale of 3.1M shares by selling stockholders
--------------------------------------------------------------------------------

- Registration covers up to 3,124,995 common shares held by certain stockholders to satisfy registration rights.
- Shares issuable upon conversion of Series A Convertible Preferred Stock sold on April 15, 2024 for $150M.
- Legal opinion of Latham & Watkins filed as Exhibit 5.1 and incorporated into S-3ASR registration statement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1649904/000110465924078941/0001104659-24-078941-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1649904/000110465924078941/tm2418975d2_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-078941

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer